Concepedia

Nathalie Merillon

NM

Statistics

Publications

8

Citations

1.4K

H-Index

8

Active since

2010

Affiliations

Inserm(Current)

Université Paris Cité

Assistance Publique – Hôpitaux de Paris

Hôpital Européen Georges-Pompidou

Paris Cardiovascular Research Center

Nathalie Merillon is an author at Inserm specializing in immunology, cancer immunotherapy, and cancer immunology.

Publications per year

2010–2021

8

Publications

8

PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

Cécile Badoual, Stéphane Hans, Nathalie Merillon et al. · Cancer Research · 2012 · 634 citations

, , +17

Mucosal Imprinting of Vaccine-Induced CD8 <sup>+</sup> T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors

Federico Sandoval, Magali Terme, Mevyn Nizard et al. · Science Translational Medicine · 2013 · 224 citations

, , +14

A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients

Olivier Adotévi, Hélène Péré, Patrice Ravel et al. · Journal of Immunotherapy · 2010 · 205 citations

, , +17

A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens

Hélène Péré, Yves Montier, Jagadeesh Bayry et al. · Blood · 2011 · 157 citations · Full text

, , +16

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer

Hélène Péré, Corinne Tanchot, Jagadeesh Bayry et al. · OncoImmunology · 2012 · 99 citations · Full text

, , +16

1–5 of 8